GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tsubota Laboratory Inc (TSE:4890) » Definitions » Debt-to-EBITDA

Tsubota Laboratory (TSE:4890) Debt-to-EBITDA : -0.06 (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Tsubota Laboratory Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Tsubota Laboratory's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was 円24.5 Mil. Tsubota Laboratory's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was 円98.5 Mil. Tsubota Laboratory's annualized EBITDA for the quarter that ended in Dec. 2023 was 円-2,187.2 Mil. Tsubota Laboratory's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was -0.06.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Tsubota Laboratory's Debt-to-EBITDA or its related term are showing as below:

TSE:4890' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -0.2   Med: 0.89   Max: 7.93
Current: -0.18

During the past 5 years, the highest Debt-to-EBITDA Ratio of Tsubota Laboratory was 7.93. The lowest was -0.20. And the median was 0.89.

TSE:4890's Debt-to-EBITDA is ranked worse than
100% of 426 companies
in the Medical Devices & Instruments industry
Industry Median: 1.26 vs TSE:4890: -0.18

Tsubota Laboratory Debt-to-EBITDA Historical Data

The historical data trend for Tsubota Laboratory's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tsubota Laboratory Debt-to-EBITDA Chart

Tsubota Laboratory Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
Debt-to-EBITDA
7.93 0.89 0.93 0.76 -0.20

Tsubota Laboratory Quarterly Data
Mar20 Mar21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.24 -0.19 -0.14 -0.06 0.09

Competitive Comparison of Tsubota Laboratory's Debt-to-EBITDA

For the Medical Devices subindustry, Tsubota Laboratory's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tsubota Laboratory's Debt-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Tsubota Laboratory's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Tsubota Laboratory's Debt-to-EBITDA falls into.



Tsubota Laboratory Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Tsubota Laboratory's Debt-to-EBITDA for the fiscal year that ended in Mar. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(26.52 + 90.38) / -599.622
=-0.19

Tsubota Laboratory's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(24.48 + 98.54) / -2187.188
=-0.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.


Tsubota Laboratory  (TSE:4890) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Tsubota Laboratory Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Tsubota Laboratory's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Tsubota Laboratory (TSE:4890) Business Description

Traded in Other Exchanges
N/A
Address
34 Shinanomachi, 304 Toshin Shinanomachi-ekimae Building, Shinjuku-ku, Tokyo, JPN, 160-0016
Tsubota Laboratory Inc is engaged in the research and development of pharmaceuticals and medical devices for the treatment of myopia, dry eyes, and presbyopia.

Tsubota Laboratory (TSE:4890) Headlines

No Headlines